THE EORTC EARLY CLINICAL-TRIALS COOPERATIVE GROUP EXPERIENCE WITH 5-AZA-2'-DEOXYCYTIDINE (NSC-127716) IN PATIENTS WITH COLO-RECTAL, HEAD AND NECK, RENAL CARCINOMAS AND MALIGNANT MELANOMAS

被引:97
|
作者
ABELE, R
CLAVEL, M
DODION, P
BRUNTSCH, U
GUNDERSEN, S
SMYTH, J
RENARD, J
VANGLABBEKE, M
PINEDO, HM
机构
[1] CTR LEON BERARD,F-69373 LYON 2,FRANCE
[2] INST JULES BORDET,B-1000 BRUSSELS,BELGIUM
[3] FIFTH MED CLIN,NURNBERG,FED REP GER
[4] DET NORSKE RADIUMHOSP,OSLO,NORWAY
[5] WESTERN GEN HOSP,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND
[6] EUROPEAN ORG RES TREATMENT CANC,CTR DATA,BRUSSELS,BELGIUM
[7] FREE UNIV AMSTERDAM HOSP,AMSTERDAM,NETHERLANDS
来源
关键词
D O I
10.1016/0277-5379(87)90060-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1921 / 1924
页数:4
相关论文
共 1 条
  • [1] 5-AZA-2'-DEOXYCYTIDINE (NSC-127716) IN NONSEMINOMATOUS TESTICULAR CANCER - PHASE-II FROM THE EORTC EARLY CLINICAL-TRIALS COOPERATIVE GROUP AND GENITOURINARY GROUP
    CLAVEL, M
    MONFARDINI, S
    FOSSA, S
    SMYTH, J
    RENARD, J
    KAYE, SB
    DROZD, A
    DODION, P
    SPLINTER, TAW
    STOTER, G
    HUININK, WWT
    ANNALS OF ONCOLOGY, 1992, 3 (05) : 399 - 400